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Abstract 
After reading this article, the pharmacist should be able to: • Provide a customer with information about 
appropriate mouth care during and following chemotherapy and radiotherapy. • Recommend appropriate 
therapy for gastrointestinal symptoms experienced post-chemotherapy and radiotherapy. • Provide a 
customer with information about appropriate skin care following chemotherapy/radiotherapy. 
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After reading this article, the pharmacist should be able to: 
• Provide a customer with information about appropriate mouth care 
during and following chemotherapy and radiotherapy. 
• Recommend appropriate therapy for gastrointestinal symptoms 
experienced post-chemotherapy and radiotherapy. 
• Provide a customer with information about appropriate skin care 
following chemotherapy/radiotherapy. 
Introduction 
Chemotherapy and radiotherapy are used in cancer treatment to promote cell 
death and apoptosis [1]. Aggressive chemotherapy and radiotherapy 
treatments can affect rapidly dividing normal cells (e.g. alimentary tract 
mucosa) [2, 3] potentially causing adverse effects such as mucositis, salivary 
gland dysfunction, taste dysfunction, ulceration, pain, bloating, vomiting and 
diarrhoea [2, 4, 5, 6]. These adverse events can lead to more serious 
complications such as dehydration, malnutrition and systemic infection which 
can negatively impact on the patient’s quality of life and morbidity [2, 5]. 
Management of alimentary tract complications, both preventive and 
therapeutic, are therefore a high priority. 
Case Study 
Mr RJ is a 55-year old, previously healthy man, who has been 
diagnosed with advanced stage 4 nasopharyngeal small cell 
carcinoma. His treatment regimen will consist of up to 8 cycles of 
cisplatin 40 mg/m2 by intravenous infusion weekly with concurrent 
radiotherapy. He will be also be given oral anti-emetics dexamethasone 
(8 mg daily) for days 2–4, and additional metoclopramide (10–20 mg 
every four hours when required). After receiving his first cycle of 
cancer treatment, Mr RJ asks your advice on maintaining good oral 
hygiene as he has been told it is extremely important. 
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1. How can Mr RJ achieve good oral hygiene? 
Ideally, Mr RJ should have been advised to visit his dentist one month prior to 
his cancer treatment as completing all necessary interventions prior to 
treatment can reduce oral complications. Mr RJ should be advised to use a 
soft bristle, small-head (manual or electric) toothbrush. He should brush his 
teeth, using a gentle small circular motion, at least twice daily using 
toothpaste which is free of the irritant detergent sodium lauryl sulphate (SLS). 
These SLS-free toothpastes, as well as fluoride treatments and/or toothpaste 
for sensitive teeth, should be highly recommended for customers who 
complain of sore ulcerated mouths with sensitive teeth[4]. Alternatively, 
amosan® sachets dissolved in water and used as a mouth rinse can be used 
instead of tooth paste [7]. Appropriate use of dental floss or dental tape, at 
least once daily could also be recommended, but only under a dentist’s advice 
when ulceration is present.  
 
In addition to teethbrushing and dental flossing, Mr RJ’s would benefit from 
regular (3–4 times per day) mouthwashes using either plain water or water 
with additives (e.g. sodium bicarbonate, sodium chloride, lemon juice, 
sodium citrotartrate)[8]. Alcohol-free over-the-counter mouth washes can 
also be recommended.  
 
2. What if a patient has dentures? 
Patients with dentures should clean them daily with a toothbrush or denture 
brush, and soak them overnight in warm water or a denture cleaner. 
Customers receiving chemotherapy and/or radiotherapy commonly 
experience significant weight loss which changes the fit of dentures. 
Dentures should be promptly adjusted by a dentist if they become loose.  
 
 Two weeks later Mr RJ returns to the pharmacy complaining of a very 
dry and painful mouth which makes it difficult for him to swallow and a 
change in the taste of his food. For the past few days after receiving his 
last cancer treatment he has had very loose stools.  
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3. How can Mr RJ treat his dry mouth? 
Mr RJ’s dry mouth (xerostomia) has probably been caused by the 
radiotherapy damaging his salivary glands. To avoid negative impacts on his 
health and nutritional status it is important it is treated appropriately [8]. Non-
pharmacological measures such as taking frequent sips of water; sucking on 
sugarless lollies, ice cubes, ice-blocks, frozen lemon slices, frozen tonic 
water; eating sugar-free pineapple pieces or chewing sugarless gum  can 
induce saliva flow.  
Alternatively, topical fluoride gel (e.g. 0.4% stannous fluoride gel) could be 
applied to his teeth each time he brushes and at night. Artificial saliva (e.g. 
(Aquae®, Biotene Oralbalance®, Oralube®) can make it easier to eat, 
swallow, talk and sleep. Applying lanolin-based preparations or lip balms can 
help to avoid dry and chapped lips [8, 9].  
4. What would you recommend to treat Mr RJ’s mouth pain? 
The Palliative Care Therapeutic Guidelines [8] and the American Cancer 
Society, Updated Mucositis Practice Guidelines [3], recommend one of 
following symptomatic treatments be used prior to undertaking his oral 
hygiene regimen (e.g. tooth brushing), and before meals.  
• Benzydamine 0.15% (Difflam®),10–15 ml rinse and spit, 4 hourly 
• Lignocaine viscous 2% (Xylocaine viscous®), 10–15 ml rinse and spit, 
4 hourly. Can be swallowed to help alleviate throat pain[7] 
• Aspirin or paracetamol gargles, 4 hourly or as required 
• Choline salicylate gel (Bonjela®, Ora-sed® gel, Seda-gel®) applied 
topically every 4–6 hours 
It is noteworthy, that benzydamine is the only mouthwash recommended by 
the Multinational Association of Supportive Care in Cancer (MASCC) which 
does not recommend the use of chlorhexidine. Other mouthwashes including 
vitamin B12 and sucralfate have been used in palliative care but there is no 
clinical evidence to support their use [7] 
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The protective paste Orabase® used alone or in combination with 
triamcinolone (Kenalog®) can be applied to ulcerated areas to reduce pain 
[7]. Anecdotally, Gelclair® has also been found to help reduce pain in mouth 
ulcers by providing a protective barrier [7]. 
5. What would you recommend for persistent mouth pain? 
If pain persists, Mr RJ may consider the regular use of a mild oral analgesic 
such as paracetamol, (avoiding NSAIDS which may promote bleeding). He 
may even require stronger opioid analgesics prescribed by his doctor or 
oncologist. In very severe cases of oral mucositis pain, patient-controlled 
analgesia (PCA) with morphine may be necessary [3, 10]. Pain may also be a 
result of infection, requiring treatment with antibiotics and/or antifungal agents 
under the direction of his doctor or oncologist. 
6. What can be done about Mr RJ’s problem with swallowing?  
Following the use of the steps described previously, if Mr RJ continues to 
have trouble swallowing he should be advised to eat small, relatively soft and 
bland meals and to avoid spicy, acidic or citrus foods/drinks and alcohol. If his 
cancer treatment has significantly reduced his appetite and hence his 
nutritional intake, you may recommend proprietary balanced nutritional 
supplements. These liquid diets and nutritional drinks can be offered as meal 
replacement or supplements to maintain calorific, vitamin and mineral intake. 
Patients who receive concomitant chemotherapy and head and/or neck 
radiotherapy often require enteral nutrition support to maintain their nutritional 
status [6]. Mr RJ should be encouraged to seek a dietician’s advice sooner 
rather than later. If hyperacidity and gastric reflux become a problem, he could 
commence either an oral proton pump inhibitor (e.g. oral omeprazole 20 mg 
daily) or oral ranitidine 300 mg daily [8].  
7. Is a change in taste common? 
Changes in taste are common side effects of chemotherapy and radiation 
therapy [6]. For some, taste returns to normal within a few months of 
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treatment, whereas for others the changes may be permanent. According to 
the US National Cancer Institute [6] zinc sulphate supplements can help with 
the recovery of taste for some patients. Mr RJ may wish to consider this 
option following the completion of his cancer treatment.  
Although not warranted in Mr RJ’s case, oral mucositis in patients receiving 
chemo-radiation can be managed with palifermin (Kepivance® a recombinant 
human keratinocyte growth factor) for haematological malignancies; or 
amifostine (Ethyol® an antioxidant) for non-small cell lung cancer and low-
level laser therapy for haematopoietic cell transplantation patients [11].  
8. Should Mr RJ be concerned about his diarrhoea? 
Abdominal pain, bloating and diarrhoea are common transient side effects of 
chemotherapy. Long-term complications associated with radiation therapy 
may include malabsorption and dysmotility [10]. Mr RJ’s diarrhoea almost 
certainly is a result of his cancer treatment and needs to be controlled to avoid 
any additional complications. Cisplatin, in particular, can cause nephrotoxicity 
which is why he needs to understand the importance of his antiemetic therapy 
and the need to be well hydrated. He should be encouraged to drink as often 
as possible, especially when he is experiencing diarrhoea symptoms. If 
diarrhoea persists he may need to take oral rehydration therapy (e.g 
Hydralyte®, Gastrolyte®, Repalyte®) and loperamide (4 mg initially, followed 
by 2 mg after each loose bowel motion,  [12] and 4 mg every 4 hours during 
the night [13]. If diarrhoea is severe and loperamide (or lofenoxal) has no 
effect then subcutaneous octreotide (100–150 mcg and increasing as 
necessary) may be useful [13].  
Other strategies currently being investigated for the prevention and/or 
treatment of cancer therapy-induced diarrhoea include: the use of non-
absorbable antibiotics (e.g. neomycin and bacitracin); kampo medicine 
(Hangeshashin-to); chrysin; bowel alkinisation and defecation control; 
activated charcoal; glutamine, thalidomide, fish oils and cox 2 inhibitors [13].  
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Mr RJ returns after his third round of cancer treatment and has lost 
almost all of his hair which he says doesn’t really bother him very much. 
He does however, complain that his skin is very dry, itchy and flaky, and 
that his finger nails have discoloured.  
 
9. Can cancer treatment affect the skin or nails? 
Alopecia is the most common cutaneous side-effect of chemotherapy, while 
transient erythema, pruritus, dry skin and hyperpigmentation are often seen 
within 2 to 4 weeks of treatment with combination chemotherapy and 
radiotherapy [4, 14]. In addition to skin reactions, such combination 
treatments can cause changes to the nails - giving them a dark, yellow or 
cracked appearance [6] with Beau’s lines (transverse white) across the nail 
plate [14].  
 
10. What can you recommend to alleviate his itchy skin symptoms? 
Because Mr RJ’s scratching could potentially introduce an infection, his dry 
itchy skin should be treated. He should use mild soaps, soap substitutes or 
bath oil; moisturising creams or lotions (aqueous based) or perhaps even 
soothing lotions containing menthol, phenol or camphor. He should always 
use sunscreen, lip balm and appropriate clothing when exposed to ultraviolet 
light, and avoid perfumed soaps, deodorants, ointment, tape, bandages. Heat 
packs or ice packs which could also exacerbate his skin irritation [4]. Short, 
tepid showers or baths, as well as cotton clothing and bedding should also be 
recommended to reduce his itching sensations.  
If shaving is painful, he could shave less frequently, use a gentle electric razor 
or even stop shaving until his skin becomes less sensitive. To help protect his 
hands and nails he should keep his fingernails short and wear gloves whilst 
working in the garden or doing household chores.  
If none of these strategies alleviate his itchy skin symptoms, Mr RJ could use 
one or more of the following:  
• topical corticosteroids[15] ; 
• antihistamines (e.g. promethazine 10–25 mg orally, 2–3 times daily or 
trimeprazine 10 mg orally 3–4 times daily [8]); and/or 
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•  antidepressants (doxepin 10–50 mg orally at night or paroxetine 20–30 
mg orally in the morning) [8]. 
In summary, Mr RJ’s cooperation with regard to good overall health care is 
integral to the success of his cancer treatment. It is your professional 
responsibility to educate him appropriately about the importance of good oral 
hygiene and nutritional intake, as well as the management of his symptoms in 
order to achieve optimal health outcomes.  
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Multiple Choice Questions 
Choose ONE correct option for each of the following questions  








2. Xerostomia is also known as: 
a) sore mouth 
b) swollen tongue 
c) sensitive tooth 
d) dry mouth 
e) soft stool 
 
3. The treatment of choice for very severe oral mucositis pain is: 
a) Aspirin 
b) Benzydamine 0.15% 
c) Lignocaine viscous 2% 
d) Paracetamol with Codeine 
e) Patient controlled analgesia (PCA) with morphine 
 







5. Which ONE of the following agents would be considered as first line 
treatment for chemotherapy/radiotherapy induced diarrhoea? 
a) Activated charcoal 







Answers: 1 (b) apoptosis ; 2. (d) dry mouth; 3. (e) Patient controlled analgesia 
(PCA) with morphine; 4. (b) nephrotoxicity; 5. (d) Loperamide 
 
 
 
